Northwell Health reports multiple tick-borne diseases beyond Lyme exist in the U.S., emphasizing prevention and awareness is crucial for safety.

Scientific breakthroughs take center stage at the International AIDS Society Conference as global HIV funding and political support erode.

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

The FDA issued a complete response letter for Regeneron's lymphoma drug odronextamab. Elsewhere, Bristol Myers raised its guidance and analysts saw progress in Biogen’s turnaround.